Delivery Order SPE2DR25D2104-SPE2DR26F3NVZ
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $4,292.21 to supply Lantus SoloStar 100 Unit/mL 3mL insulin pens, with completion scheduled for August 6, 2025. The award was issued on August 5, 2025, using firm fixed-price pricing with no set-aside designation, indicating competitive selection. Performance of this delivery order is based in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order falls under...
- AmerisourceBergen Drug Corp was awarded a $1,197.07 firm fixed-price delivery order by the Defense Logistics Agency on July 18, 2025, for Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a non-set-aside competitive award with an ultimate completion date of July 21, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp has been awarded a firm fixed-price delivery order valued at $1,278.50 by the Defense Logistics Agency (DLA) for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The award, issued on August 8, 2025, represents a competitive procurement with no set-aside designation and is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $4,398.30. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for Lantus SoloStar 100 Unit/mL insulin pens with a ceiling value of $1,022.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.88 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 17, 2025, for Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $3,414.70. This firm fixed price delivery order, with an ultimate completion date of June 18, 2025, represents a single-unit transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award...
- The Defense Logistics Agency awarded a $4,038.26 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 13, 2025, with an ultimate completion date of June 16, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,443.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with an ultimate completion date of November 5, 2025. This competitive, firm fixed-price delivery order was issued on November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's ability to compete in open...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NVZDelivery Order
AmerisourceBergen Drug Corp has been awarded a competitively competed delivery order by the Defense Logistics Agency (DLA) for Lantus SoloStar 100 Unit/ML insulin pens, valued at $1,294.28. The order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery requirement from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military healthcare systems globally. The Lantus insulin delivery supports the Defense Health Agency and military medical programs requiring diabetes management pharmaceuticals, demonstrating the contractor's critical role in federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/12/25 |